+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis



Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis



American Journal of the Medical Sciences 313(1): 23-32




(PDF emailed within 0-6 h: $19.90)

Accession: 002973865

Download citation: RISBibTeXText

PMID: 9001163

DOI: 10.1016/S0002-9629(15)40038-2


Related references

Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis. Archives of Internal Medicine 161(19): 2325-2333, 2001

Slow-release sodium fluoride in the management of postmenopausal osteoporosis. Fluoride 27(4): 227-228, 1994

Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Annals of Internal Medicine 120(8): 625-632, 1994

Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: A randomized 3 year trial. Bone (New York) 27(1): 123-128, July, 2000

Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. Journal of Bone and Mineral Research 1(6): 563-571, 1986

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride Critique of final report from C Y C pak et al. Fluoride. 29(1): 36-37, 1996

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Annals of Internal Medicine 123(6): 401-408, 1995

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis. Journal of Bone and Mineral Research 11(2): 160-168, 1996

Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis. Osteoporosis International 14(6): 500-506, 2003

The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism and blood chemistry in postmenopausal osteoporosis. Calcified Tissue International 61(4): 272-278, 1997

Treatment of postmenopausal osteoporosis with sodium fluoride. La Revue de Medecine Interne 4(2): 111-113, 1983

Sodium fluoride therapy of postmenopausal osteoporosis. Endocrine Reviews 14(3): 312-323, 1993

Postmenopausal osteoporosis: treatment with low-dose sodium fluoride and estrogen. Southern Medical Journal 81(5): 597-600, 1988